Validation of the Newly Developed Fully Automated Chemiluminescent Enzyme Immunoassay (CLEIA) Reagent for Measurement of Cyclosporine in the Blood

被引：0
|
作者：
Tanaka, M. [1 ]
Yui, H. [1 ]
Baba, K. [1 ]
Oshimo, A. [1 ]
Hara, A. [1 ]
Tanaka, M. [1 ]
Ishii, Y. [1 ]
Kaneko, A. [1 ]
Aoyagi, K. [1 ]
机构：
[1] FUJIREBIO INC, Hachioji, Tokyo, Japan
来源：
CLINICAL CHEMISTRY | 2024年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B-267
引用
收藏
页数：2
相关论文
共 34 条
  • [21] Validation and evaluation of a newly developed time-resolved fluoroimmunoassay for cyclosporine quantitative analysis in human whole blood
    Wang, Xuebin
    Gao, Yuan
    Yang, Yunyun
    Liu, Zhengyue
    Gao, Lihong
    Wu, Fengbo
    Yang, Xianmi
    Xu, Xiaojian
    Wang, Zhuo
    Sun, Shusen
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 177
  • [22] New Screening Cutoff Values For Detection Of Aldosteronoma Examined By Lc-ms/ms And A Newly Developed Non-competitive Chemiluminescent Enzyme Immunoassay
    Satoh, Fumitoshi
    Ono, Yoshikiyo
    Omata, Kei
    Tezuka, Yuta
    Ito, Sadayoshi
    HYPERTENSION, 2023, 80
  • [23] Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassay
    van Helden, Josef
    Weiskirchen, Ralf
    CLINICAL BIOCHEMISTRY, 2018, 62 : 32 - 38
  • [24] Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
    Honma, Ken-ichiro
    Nakayama, Yoshiro
    Tamaki, Atsuko
    Uehara, Moriyuki
    Teruya, Taiki
    Yabiku, Takamitsu
    Ishiki, Yohei
    Yonaha, Ken
    Chinen, Rei
    Uema, Tsugumi
    Okamoto, Shiki
    Masuzaki, Hiroaki
    ENDOCRINE JOURNAL, 2024, 71 (09) : 895 - 906
  • [25] A Newly Developed High-Sensitive HBsAg Chemiluminescent Enzyme Immunoassay is a Precise Application as a pre-Transfusion Screening Test to Detect Occult HBV
    Inoue, Takako
    Ohne, Kumiko
    Ochi, Noriyo
    Shinkai, Noboru
    Murakami, Shuko
    Iijima, Sayuki
    Ogawa, Shintaro
    Watanabe, Tsunamasa
    Tanaka, Yasuhito
    HEPATOLOGY, 2014, 60 : 1003A - 1003A
  • [26] Application of a newly-developed high sensitivity HBsAg chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B patients with HBs Ag seroclearance
    Shinkai, Noboru
    Iio, Etsuko
    Watanabe, Tsunamasa
    Matsuura, Kentaro
    Endo, Mio
    Fujiwara, Kei
    Nojiri, Shunsuke
    Takashi, Joh
    Tanaka, Yasuhito
    HEPATOLOGY, 2013, 58 : 724A - 724A
  • [27] Fully automated enzyme immunoassay system for the determination of activator-specific histamine release from basophils in whole blood
    Zia, PK
    Namei, N
    Patel, A
    Kontis, KJ
    Nayak, N
    Chen, R
    Li, TM
    CLINICAL CHEMISTRY, 1998, 44 (09) : 2063 - 2065
  • [28] COMPARISON OF CYCLOSPORINE MEASUREMENT IN WHOLE-BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, MONOCLONAL FLUORESCENCE POLARIZATION IMMUNOASSAY, AND MONOCLONAL ENZYME MULTIPLIED IMMUNOASSAY
    DUSCI, LJ
    HACKETT, LP
    CHISWELL, GM
    ILETT, KF
    THERAPEUTIC DRUG MONITORING, 1992, 14 (04) : 327 - 332
  • [29] The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device
    Kengo Nishimura
    Hiroaki Kitazawa
    Takashi Kawahata
    Kosuke Yuhara
    Takahiro Masuya
    Toshihiro Kuroita
    Kentarou Waki
    Seiichi Koike
    Masaharu Isobe
    Nobuyuki Kurosawa
    BMC Immunology, 24
  • [30] The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device
    Nishimura, Kengo
    Kitazawa, Hiroaki
    Kawahata, Takashi
    Yuhara, Kosuke
    Masuya, Takahiro
    Kuroita, Toshihiro
    Waki, Kentarou
    Koike, Seiichi
    Isobe, Masaharu
    Kurosawa, Nobuyuki
    BMC IMMUNOLOGY, 2023, 24 (01)
1234